News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lipoxen (LPX.L) Raises £2.6 Million Through Strategic Placing And Warrant Agreement With Serum Institute of India, Ltd.



8/3/2006 5:20:10 PM

Lipoxen PLC (AIM: LPX), a biopharmaceutical company specialising in the development of differentiated biologicals, vaccines and oncology drugs, today announced that it had raised £2.6 million in new funds from the Serum Institute of India Limited ("SIIL") through a subscription agreement and associated warrant agreement.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES